Indivior

INDV US Health Care Pharmaceuticals
S&P 600
$34.49
-0.06%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of -1.53.
  • Comfortable interest cover: operating profit covers interest about 6.9 times.
  • Return on capital employed is healthy at 82.1%.
  • Net profit margin is strong at 17%.

!Watch-points

  • Return on equity is on the lower side at -101%.
  • Current ratio of 0.71 is below 1, so current liabilities exceed current assets.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.24

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Piotroski F-ScoreWeak
3 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$4.07B
Current Price$ 34.49
High / Low$ 42.81 / 22.22
Stock P/E12.362008
Book Value$ -1.68
Dividend Yield0%
ROCE82.13%
ROE-100.96%
Debt to Equity-1.53
Current Ratio0.71
P/B Ratio-19.563246
EPS$ 1.64
Debt$319.00M
PAT Margin16.95%
Cash PAT$220.00M
ICR6.89
Educational data only. Not a recommendation to buy, sell or hold any security.